LOTRISONE Cream Ref.[10590] Active ingredients: Betamethasone Clotrimazole

Source: FDA, National Drug Code (US) Revision Year: 2020

1. Indications and Usage

LOTRISONE cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in patients 17 years and older.

2. Dosage and Administration

Treatment of tinea corporis or tinea cruris:

Apply a thin film of LOTRISONE cream into the affected skin areas twice a day for one week.
Do not use more than 45 grams per week. Do not use with occlusive dressings.
If a patient shows no clinical improvement after 1 week of treatment with LOTRISONE cream, the diagnosis should be reviewed.
Do not use longer than 2 weeks.

Treatment of tinea pedis:

Gently massage a sufficient amount of LOTRISONE cream into the affected skin areas twice a day for two weeks.
Do not use more than 45 grams per week. Do not use with occlusive dressings.
If a patient shows no clinical improvement after 2 weeks of treatment with LOTRISONE cream, the diagnosis should be reviewed.
Do not use longer than 4 weeks.

LOTRISONE cream is for topical use only. It is not for oral, ophthalmic, or intravaginal use.

Avoid contact with eyes. Wash hands after each application.

16.2. Storage and Handling

Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.